Great Lakes Advisors LLC bought a new stake in shares of Avanos Medical Inc (NYSE:AVNS) in the 3rd quarter, HoldingsChannel.com reports. The fund bought 165,041 shares of the company’s stock, valued at approximately $11,305,000.
Several other institutional investors have also made changes to their positions in the company. Oregon Public Employees Retirement Fund acquired a new position in Avanos Medical in the second quarter worth about $1,033,000. Public Employees Retirement System of Ohio acquired a new position in Avanos Medical in the second quarter worth about $136,000. McQueen Ball & Associates Inc. acquired a new position in Avanos Medical in the third quarter worth about $268,000. CENTRAL TRUST Co acquired a new position in Avanos Medical in the third quarter worth about $167,000. Finally, Fox Run Management L.L.C. acquired a new position in Avanos Medical in the third quarter worth about $704,000. Institutional investors own 86.75% of the company’s stock.
Shares of NYSE AVNS opened at $47.71 on Friday. The company has a current ratio of 2.78, a quick ratio of 2.32 and a debt-to-equity ratio of 0.19. Avanos Medical Inc has a 52-week low of $42.80 and a 52-week high of $72.96. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of 20.30 and a beta of 1.86.
In other Avanos Medical news, CFO Steven E. Voskuil bought 2,000 shares of the business’s stock in a transaction on Tuesday, November 27th. The shares were purchased at an average price of $43.74 per share, with a total value of $87,480.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Joseph Fralin Woody bought 3,500 shares of the business’s stock in a transaction on Wednesday, November 28th. The stock was acquired at an average cost of $43.35 per share, for a total transaction of $151,725.00. The disclosure for this purchase can be found here. Insiders acquired 6,500 shares of company stock worth $286,685 in the last three months. 1.44% of the stock is currently owned by corporate insiders.
A number of equities analysts recently commented on the company. TheStreet downgraded Avanos Medical from a “b-” rating to a “c” rating in a research note on Wednesday, November 7th. Zacks Investment Research downgraded Avanos Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, November 7th. Barclays assumed coverage on Avanos Medical in a research note on Monday, October 15th. They issued an “equal weight” rating and a $69.00 price target for the company. Morgan Stanley lifted their price target on Avanos Medical from $60.00 to $62.00 and gave the stock an “underweight” rating in a research note on Thursday, October 11th. Finally, Raymond James upgraded Avanos Medical from a “market perform” rating to an “outperform” rating in a research note on Tuesday, August 21st. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the company’s stock. Avanos Medical presently has an average rating of “Hold” and a consensus price target of $69.25.
ILLEGAL ACTIVITY WARNING: This news story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.com-unik.info/2018/12/01/great-lakes-advisors-llc-buys-shares-of-165041-avanos-medical-inc-avns.html.
Avanos Medical Company Profile
Avanos Medical, Inc operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management.
Read More: Do Tariffs Work?
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical Inc (NYSE:AVNS).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.